title: Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease.
authors.affiliation: Inserm UMRS, Institut du Fer à Moulin, Paris, FranceDepartments of Histology Pathology The Memory Clinical Center, Lariboisière Hospital (APHP), University Paris Diderot VII, Paris, France.
authors.forename: Anindita
authors.initials: A
authors.lastname: Bose
authors.forename: François
authors.initials: F
authors.lastname: Mouton-Liger
authors.forename: Claire
authors.initials: C
authors.lastname: Paquet
authors.forename: Pierre
authors.initials: P
authors.lastname: Mazot
authors.forename: Marc
authors.initials: M
authors.lastname: Vigny
authors.forename: Françoise
authors.initials: F
authors.lastname: Gray
authors.forename: Jacques
authors.initials: J
authors.lastname: Hugon
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D015153:Blotting, Western; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D002460:Cell Line; D004789:Enzyme Activation / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D007150:Immunohistochemistry; D018613:Microscopy, Confocal; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D010766:Phosphorylation; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D019892:eIF-2 Kinase / Q000378:metabolism*; D016875:tau Proteins / Q000187:drug effects / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D016875:tau Proteins; C000605506:GSK3B protein, human; D000071679:Glycogen Synthase Kinase 3 beta; D019892:eIF-2 Kinase; D038362:Glycogen Synthase Kinase 3